BeyondSpring: Said it Intends To Defend Itself In Its Dispute With Hengrui
-6-K
As previously reported on a Form 6-K filed by BeyondSpring Inc. (the “Company”), Dalian Wanchunbulin Pharmaceuticals Ltd. (“Wanchunbulin”), the Company’s 58%-owned subsidiary in China,